三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
中国按疾病的严重性划分的特应性皮炎药物市场明细(百万美元)
中国按疾病的严重性划分的特应性皮炎药物市场明细(百万美元)
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:101KB
图片尺寸:2199*782
同报告图片
/
4
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
所属报告:
康诺亚~B-港股公司研究报告-自免肿瘤双管齐下ADC授权乘风出海-230728(45页).pdf
打包全文图表
相关数据
图6、全球主要治疗特应性皮炎创新药物年度销售(亿美元)
fCDlubTku70gfCDluqbmma7liKnlsKTljZXmipfvvIjkur/nvo7lhYPvvIkgfCDkuYzluJXmm7/lsLzvvIjkur/nvo7lhYPvvIkgfAp8LS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLXwKfCAyMDE5IHwgMjMuMjMgICAgICAgICAgICAgICAgICB8IDAuNDcgICAgICAgICAgICAgICB8CnwgMjAyMCB8IDM5LjIzICAgICAgICAgICAgICAgICAgfCA3LjMxICAgICAgICAgICAgICAgfAp8IDIwMjEgfCA2MS4yMSAgICAgICAgICAgICAgICAgIHwgMTYuNTEgICAgICAgICAgICAgIHwKfCAyMDIyIHwgODcuMzEgICAgICAgICAgICAgICAgICB8IDI1LjIyICAgICAgICAgICAgICB8CnwgMjAyMyB8IDExNC42OSAgICAgICAgICAgICAgICAgfCAzOS42OSAgICAgICAgICAgICAgfAp8IDIwMjQgfCAxNDEuNDcgICAgICAgICAgICAgICAgIHwgNTkuNzEgICAgICAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muWMu+iNr+mtlOaWue+8jGRydWdkaXNjb3Zlcnl0cmVuZHPvvIzlhbTkuJror4HliLjnu4/mtY7kuI7ph5Hono3noJTnqbbpmaLmlbTnkIY=
收藏
行业数据
2026-01-05
原图定位
查看详情
特应性皮炎全球发病率
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
收藏
行业数据
2025-12-19
原图定位
查看详情
2024年中国COPD、特应性皮炎和哮喘等适应症人数排名靠前(万人)
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
收藏
行业数据
2025-11-13
原图定位
查看详情
2017年以来针对特应性皮炎的多款药物陆续获批,新靶点探索仍在持续
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
收藏
行业数据
2025-09-17
原图定位
查看详情
2017年以来针对特应性皮炎的多款药物陆续获批,新靶点探索仍在持续
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
收藏
行业数据
2025-09-17
原图定位
查看详情
2018-2030中国特应性皮炎市场规模(百万美元)
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
收藏
市场规模
2025-09-09
原图定位
查看详情
Remitch中国III期桥实验瘙痒严重性VAS值数
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
收藏
行业数据
2025-08-13
原图定位
查看详情
Bosakitug与特泽利尤单抗治疗特应性皮炎的疗效对比
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
收藏
行业数据
2025-08-01
原图定位
查看详情
Bosakitug针对中重度特应性皮炎的美国IIa期临床结果
fCDml7bpl7TvvIjlkajvvIkgfCBFQVNJIDc1IHwgRUFTSSA5MCB8IEVBU0kgMTAwIHwgSUdBIDAvMSB8CnwgOi0tOiB8IDotLTogfCA6LS06IHwgOi0tOiB8IDotLTogfAp8IDAgfCAwIHwgMCB8IDAgfCAwIHwKfCA0IHwgMjAgfCAxMCB8IDUgfCA1IHwKfCA4IHwgNDAgfCAyMCB8IDEwIHwgMTAgfAp8IDEyIHwgNjAgfCAzMCB8IDE1IHwgMTUgfAp8IDE2IHwgNzAgfCA0MCB8IDIwIHwgMjAgfAp8IDIwIHwgODAgfCA1MCB8IDI1IHwgMjUgfAp8IDI0IHwgOTAgfCA2MCB8IDMwIHwgMzAgfAp8IDI4IHwgOTUgfCA3MCB8IDM1IHwgMzUgfAp8IDMyIHwgOTAgfCA2NSB8IDMwIHwgMzAgfAp8IDM2IHwgODAgfCA2MCB8IDI1IHwgMjUgfAoK6LWE5paZ5p2l5rqQ77yaQWNsYXJpcyBUaGVyYXBldXRpY3PvvIzmi5vpk7blm73pmYXnjq/nkIPluILlnLo=
收藏
行业数据
2025-08-01
原图定位
查看详情
Bosakitug与竞品的疗效对比(特应性皮炎适应症)
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
收藏
行业数据
2025-08-01
原图定位
查看详情
中国特应性皮炎市场规模(亿元)和YOY
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
收藏
市场规模
2025-07-02
原图定位
查看详情
2018-2030E中国特应性皮炎市场规模(亿美元)
fCDlubTku70gICB8IOeUn+eJqeWItuWJgiB8IOWwj+WIhuWtkOiNr+eJqSB8IOWNoOeUn+eJqeWItuWJguavlOS+iyB8CnwtLS0tLS0tLXwtLS0tLS0tLS0tfC0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tfAp8IDIwMTggICB8IDUuMCAgICAgIHwgMC4wICAgICAgICB8IDAuMDAlICAgICAgICAgIHwKfCAyMDE5ICAgfCA1LjUgICAgICB8IDAuMCAgICAgICAgfCAwLjAwJSAgICAgICAgICB8CnwgMjAyMCAgIHwgNi4xICAgICAgfCAwLjEgICAgICAgIHwgMi4yMCUgICAgICAgICAgfAp8IDIwMjEgICB8IDcuMiAgICAgIHwgMC45ICAgICAgICB8IDEwLjkwJSAgICAgICAgIHwKfCAyMDIyICAgfCA2LjkgICAgICB8IDIuNyAgICAgICAgfCAyOC4yMCUgICAgICAgICB8CnwgMjAyM0UgIHwgNy4wICAgICAgfCA1LjkgICAgICAgIHwgNDUuODAlICAgICAgICAgfAp8IDIwMjRFICB8IDcuMyAgICAgIHwgMTAuNSAgICAgICB8IDU5LjEwJSAgICAgICAgIHwKfCAyMDI1RSAgfCA4LjUgICAgICB8IDE2LjMgICAgICAgfCA2NS44MCUgICAgICAgICB8CnwgMjAyNkUgIHwgMTAuNCAgICAgfCAyMi43ICAgICAgIHwgNjguNjAlICAgICAgICAgfAp8IDIwMjdFICB8IDExLjkgICAgIHwgMjkuOCAgICAgICB8IDcxLjQwJSAgICAgICAgIHwKfCAyMDI4RSAgfCAxMy4zICAgICB8IDM3LjcgICAgICAgfCA3My45MCUgICAgICAgICB8CnwgMjAyOUUgIHwgMTQuNyAgICAgfCA0NS44ICAgICAgIHwgNzUuNzAlICAgICAgICAgfAp8IDIwMzBFICB8IDE1LjkgICAgIHwgNTQuOCAgICAgICB8IDc3LjUwJSAgICAgICAgIHwKCui1hOaWmeadpea6kO+8muiNg+S/oeeUn+eJqeaLm+iCoeS5pu+8jOS4nOWQtOivgeWIuOeglOeptuaJgA==
收藏
市场规模
2025-06-10
原图定位
查看详情
611治疗特异性皮炎的EASI75及NRS优于度普利尤单抗(II期数据)
fCBDb21wYW55IHwgSW5kaWNhdGlvbiB8IENvZGUgfAp8IC0tLSB8IC0tLSB8IC0tLSB8CnwgQSB8IEFEIGFwcHJvdmVkIHwgIHwKfCBCIHwgQXN0aG1hIE5EQSByZXZpZXdpbmcgfCAgfAp8IDNTQmlvIHwgQXN0aG1hIFBoYXNlIElJIGNvbXBsZXRlZCB8ICB8CnwgIHwgQUQgUGhhc2UgSUlJIHwgIHwKfCAgfCBDUlN3TlAgUGhhc2UgSUlJIHwgIHwKfCAgfCBDT1BEIFBoYXNlIElJIHwgIHwKfCAgfCBTU0dKLTYxMSB8ICB8CgrotYTmlpnmnaXmupDvvJrkuInnlJ/liLboja/lhazlj7jlrpjnvZHvvIzlm73nm5vor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-03-24
原图定位
查看详情
2019-2023年皮炎平(复方醋酸地塞米松乳膏)零售额
5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yM5Lul5Y+K6LWE5paZ5p2l5rqQ77yaCgp8IOW5tOS7vSB8IOmbtuWUrumine+8iOS6v+WFg++8iSB8IOWinumVv+eOhyB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLXwKfCAyMDE5IHwgNC4xICAgICAgICAgICAgfCAwJSAgICAgfAp8IDIwMjAgfCA0LjEgICAgICAgICAgICB8IDAlICAgICB8CnwgMjAyMSB8IDQuNCAgICAgICAgICAgIHwgNyUgICAgIHwKfCAyMDIyIHwgNC4yICAgICAgICAgICAgfCAtNSUgICAgfAp8IDIwMjMgfCA0LjggICAgICAgICAgICB8IDEzJSAgICB8CgrotYTmlpnmnaXmupDvvJrkuK3lurflvIDmgJ3vvIzkuJzmlrnor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-02-25
原图定位
查看详情
2019-2023年皮炎平(糠酸莫米松凝胶)零售额(亿
5Lul5LiL5piv5o+Q5Y+W55qE5pWw5o2u5bm255Sf5oiQ55qE6KGo5qC877yaCgp8IOW5tOS7vSB8IOmbtuWUrumine+8iOS6v+WFg++8iSB8IOWinumVv+eOhyB8CnwtLS0tLS18LS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLXwKfCAyMDE5IHwgMi41ICAgICAgICAgICAgfCAgICAgICAgfAp8IDIwMjAgfCAyLjQgICAgICAgICAgICB8IC0zJSAgICB8CnwgMjAyMSB8IDIuOSAgICAgICAgICAgIHwgMjElICAgIHwKfCAyMDIyIHwgMy41ICAgICAgICAgICAgfCAxNyUgICAgfAp8IDIwMjMgfCA0LjIgICAgICAgICAgICB8IDIxJSAgICB8CgrotYTmlpnmnaXmupDvvJrkuK3lurflvIDmgJ3vvIzkuJzmlrnor4HliLjnoJTnqbbmiYA=
收藏
行业数据
2025-02-25
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
中国特应性皮炎药物市场迅速增长,度普利尤单抗国内获批。特应性皮炎(AD)是最常见的慢性炎症性瘙痒疾病之一,尤其是对儿童而言。据弗若斯特沙利文统计,中国 AD 患者总数于 2019 年已达到 0.66 亿例,2015 年至 2019 年的年复合增长率为 2.8%,其中大多数为儿童及青少年;预计中国 AD 患者总数于 2024 年将达到 0.74 亿例,并将于 2030 年进一步增至 0.82 亿例。此外,中国的特应性皮炎药物市场预期将由 2019 年的6 亿美元增至 2024 年的 15 亿美元,年复合增长率为 22.6%,并于 2030 年进一步增至 43 亿美元,2024 年至2030 年的年复合增长率为 18.6%。度普利尤单抗于 2020 年 6 月在国内首次获批上市,用于治疗成人中重度特应性皮炎,随后陆续申报两项适应症,分别针对 12 岁及以上的中重度特应性皮炎患者、以及 6~12 岁的中重度特应性皮炎患者,均以儿童用药的理由纳入优先审评审批并获批。
行业数据
原图定位
当前图表所属:
康诺亚~B-港股公司研究报告-自免肿瘤双管齐下ADC授权乘风出海-230728(45页).pdf
同适应症下同靶点在研产品竞争格局(II期临床及以后)
CMG901Ia期临床研究数据更新
胃癌相关适应症的在研CLDN-18.2靶向药
已上市胃癌靶向药销售情况
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》